Serological Diagnosis of Leptospirosis by Microscopic Agglutination Test

Introduction

The microscopic agglutination test (MAT) remains the reference standard for serological diagnosis of leptospirosis in veterinary medicine and wildlife surveillance [1, 2]. The MAT detects antibodies against the spirochete Leptospira spp. by observing visible agglutination of live leptospiral antigen suspensions following incubation with serial dilutions of serum [3, 4]. Despite the development of molecular methods such as polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP), MAT retains primacy due to its serovar-specific resolution and established role in epidemiological investigations [5, 6, 7]. This article provides an exhaustive technical review of the MAT for veterinary diagnosticians, immunologists, and computational biologists, with emphasis on assay physics, interpretation criteria, cross-reactivity phenomena, and emerging computational enhancements.

Biological and Biophysical Basis of the MAT

The MAT relies on the interaction between polyclonal immunoglobulins (primarily IgG and IgM) in a test serum sample and surface lipopolysaccharide (LPS) antigens expressed on live Leptospira cells [8, 9]. Leptospira LPS is the dominant immunogen driving the serovar-specific antibody response; antibodies against outer membrane proteins (e.g., OmpL1, LipL32) are less serovar-restricted and contribute to cross-reactivity [10, 11]. When specific antibodies bind to homologous serovar antigens at sufficient concentration, cross-linking of motile spirochetes occurs, forming visible aggregates (agglutinates) that can be observed by dark-field microscopy [12].

The test is performed by mixing equal volumes (typically 50 µL) of two-fold serial dilutions of heat-inactivated serum with live leptospiral cultures adjusted to a standard density (approximately 1–2 × 10⁸ organisms/mL) [13, 14]. After incubation at 28–30 °C for 2–4 hours, a drop of each mixture is examined under a dark-field microscope at 100× to 200× magnification [15]. The endpoint titre is defined as the highest serum dilution showing 50% agglutination (i.e., approximately half the leptospires remain free and motile, half are clumped) relative to a control well containing only antigen and phosphate-buffered saline [16, 17].

Standard Antigen Panels for Domestic and Wildlife Species

The accuracy of MAT depends critically on the panel of live Leptospira serovars used as antigens [1, 18]. Most veterinary diagnostic laboratories employ a panel of 12 to 24 serovars representing the predominant circulating serogroups in a given geographic region [4, 7]. Serovars are maintained in liquid culture medium (e.g., Ellinghausen-McCullough-Johnson-Harris medium) and subcultured weekly to ensure viability and motility [19, 20].

Table 1 lists commonly included serovars in veterinary MAT panels for domestic species.

Table 1. Representative Leptospira serovars included in veterinary MAT antigen panels.

Selection of serovars should be informed by local epidemiological data [2, 5]. Serological surveys in ring-tailed coatis (Nasua nasua) have demonstrated exposure to serogroups Icterohaemorrhagiae and Grippotyphosa, highlighting the need for regionally tailored panels in wildlife [1]. Similarly, studies in bats from Brazil have detected antibodies against Sejroe and Ballum serogroups, indicating sylvatic cycles that may escape detection with standard canine-feline panels [20].

Methodology: Step-by-Step Procedure

The MAT protocol requires adherence to standardized procedures to minimise inter-laboratory variation [21]. The following steps are critical:

1. Serum collection and processing. Whole blood is collected without anticoagulant and allowed to clot. Serum is separated by centrifugation and heat-inactivated at 56 °C for 30 minutes to inactivate complement and reduce non-specific agglutination [22].
2. Antigen preparation. Live leptospiral cultures are grown to late log phase (approximately 7–10 days), checked for motility and absence of autoagglutination, then diluted to an optical density equivalent to a McFarland standard of 0.5 (approximately 1–2 × 10⁸ cells/mL) [23].
3. Dilution and incubation. Serum is serially diluted two-fold in 96-well round-bottom plates, typically starting at 1:25 or 1:50. Equal volumes of antigen suspension are added. Plates are sealed and incubated at 28–30 °C for 2–4 hours [12, 24].
4. Reading. A 10 µL aliquot from each dilution well is placed on a glass slide and examined under dark-field microscopy. The titre is recorded as the reciprocal of the highest dilution showing 50% agglutination [16, 25].
5. Quality control. Positive and negative control sera of known titre are included in each run. Antigen self-agglutination controls (serum diluent plus antigen only) are mandatory [19].

Interpretation of MAT Results

Titre Thresholds and Diagnostic Criteria

Interpretation of MAT titres requires knowledge of the vaccinal status, clinical presentation, and host species [4, 26]. In unvaccinated animals, a single MAT titre of 1:100 or greater is considered presumptive evidence of past or current infection [2, 7]. For acute leptospirosis, a four-fold or greater rise in titre between paired acute and convalescent samples (collected 10–14 days apart) is required for definitive serological confirmation [5, 18]. Paired serology remains the gold standard but is rarely obtained in practice because animals may present late in the disease course [9].

Table 2 summarises commonly used titre interpretations in major domestic species.

Table 2. Diagnostic interpretation of single MAT titres in selected domestic species.

These thresholds are derived from field studies and are influenced by background seroprevalence and vaccination history [17, 27]. Vaccinated animals may maintain MAT titres of 1:100 to 1:400 for months after immunisation, complicating interpretation [27, 28].

Cross-Reactivity and Host Species Effects

Cross-reactivity between serogroups is a well-recognised limitation of the MAT [24]. Sera from animals infected with one serovar frequently agglutinate heterologous serovars, particularly those within the same serogroup or with shared LPS epitopes [14, 24]. Mummah et al. systematically demonstrated that cross-reactivity patterns vary by host species and that no single fixed threshold can universally discriminate between homologous and heterologous reactions [24]. The study recommended that laboratories report all serovars with positive reactions and designate the serovar yielding the highest titre as the presumptive infecting serogroup, a practice termed the "serogroup rule" [24].

Vaccine-induced antibodies also interfere with MAT interpretation [27]. Martínez et al. demonstrated that cattle vaccinated with a commercial bacterin maintained MAT titres against vaccine serovars (e.g., Hardjo, Pomona) for extended periods, potentially confounding field diagnosis of natural infection [27]. The study advised that a minimum cut-off of 1:400 be applied in vaccinated cattle to improve specificity [27].

Comparative Performance: MAT versus Alternative Serological Assays

MAT versus ELISA

Enzyme-linked immunosorbent assays (ELISAs) offer higher throughput and do not require live cultures, but they generally lack serovar specificity [29]. Boonciew et al. modified an ELISA using local serovar isolates from asymptomatic dogs and reported improved sensitivity (92%) and specificity (89%) compared to MAT for detection of anti-leptospiral IgG [29]. However, ELISA cannot discriminate the infecting serovar, which is critical for epidemiological surveillance and vaccine strain selection [14, 30].

Recombinant antigen-based assays have been developed to address these limitations. Kumar et al. evaluated a latex agglutination test employing the recombinant ErpY-like protein from Leptospira interrogans and reported moderate concordance with MAT in cattle and dogs [23]. Cardoso et al. developed a chimeric recombinant protein (rErpY-LemA) and demonstrated improved sensitivity in experimentally infected animals [14]. Gautam et al. described a gold nanoparticle-based lateral flow assay using recombinant Loa22, achieving 80–85% agreement with MAT in canine and bovine field sera [5]. Despite these advances, none of these assays have yet replaced MAT for serovar-level serodiagnosis.

MAT versus Molecular Methods

Molecular methods (PCR, LAMP) detect leptospiral DNA and are most useful during the acute bacteraemic phase, before antibodies are detectable [9, 16]. Hamer et al. directly compared LAMP, PCR, and MAT in cattle and found that MAT detected more seropositive animals overall, but PCR and LAMP were superior for detecting active renal shedding [9]. Ciurariu et al. reviewed diagnostic test comparisons and concluded that MAT and PCR are complementary: MAT provides serovar-level serological evidence, while PCR confirms current infection and identifies shedding animals [16]. In outbreak settings, combined use of MAT and molecular methods is recommended [2, 31].

Computational and Technological Advances in MAT Reading

Deep Learning and Automated Image Analysis

Manual reading of MAT is subjective, labour-intensive, and requires skilled microscopists [8, 13]. Inter-observer variability in endpoint determination is a known source of diagnostic discordance [7]. Recent advances in machine learning have targeted automated interpretation of MAT reactions.

Nakano et al. developed a deep learning model that emulates visual assessments by trained microscopists [8]. The model was trained on dark-field images of MAT reactions across multiple dilution series and achieved over 90% agreement with expert readers when classifying reactions as positive or negative at the 50% agglutination threshold. Hassan et al. employed a deep convolutional neural network (CNN) on MAT image datasets and reported comparable performance, with area under the receiver operating characteristic curve (AUC) values exceeding 0.95 [13]. These models, once validated across diverse serovars and host species, could standardise MAT reading and reduce inter-laboratory variation [24].

Challenges for Automation

Automated MAT reading faces several obstacles. Variation in leptospire motility across culture batches, non-specific debris in sera, and differences in microscope illumination all affect image quality [8, 13]. Furthermore, the model must generalise across multiple serovars and host species without overfitting to specific training conditions [24]. Nakano et al. cautioned that models trained on one laboratory's culture conditions may not transfer directly to another laboratory without retraining or domain adaptation [8].

Mermaid Workflow Diagram

The following Mermaid flowchart summarises the MAT workflow from sample reception to result reporting.

flowchart TD
    A[Serum sample received], > B[Heat inactivation 56°C 30 min]
    B, > C[Serial two-fold dilutions in 96-well plate]
    C, > D[Add live leptospiral antigens (panel of serovars)]
    D, > E[Incubate 28-30°C 2-4 hours]
    E, > F{Examine by dark-field microscopy}
    F, > G[Determine 50% agglutination endpoint for each serovar]
    G, > H[Record titre as reciprocal of highest positive dilution]
    H, > I{Apply diagnostic criteria}
    I, > J[Single titre ≥ threshold for species]
    I, > K[Paired samples with 4-fold rise]
    J, > L[Report serovars with titres above cut-off]
    K, > L
    L, > M[Designate presumptive infecting serogroup]
    M, > N[Interpretation with consideration of vaccination history]
    N, > O[Final diagnostic report]

Frequently Asked Questions

What is the principle of the microscopic agglutination test?

The MAT detects anti-leptospiral antibodies in serum by observing visible agglutination of live leptospires when cross-linked by specific immunoglobulins, observed by dark-field microscopy [3, 12].

What is the recommended cut-off titre for a positive MAT result in dogs?

A single MAT titre of 1:100 or greater is considered presumptive positive in dogs, but a titre of 1:800 or higher is more suggestive of recent or active infection [2, 7].

How does vaccination affect MAT interpretation?

Vaccination induces MAT titres that can persist at 1:100 to 1:400 levels for months, making it difficult to distinguish vaccine response from natural infection [27, 28]. Higher cut-offs (e.g., 1:400 in cattle) are recommended in vaccinated populations [27].

Can MAT distinguish between infecting serovars?

MAT can identify the presumptive infecting serogroup based on the highest titre, but cross-reactivity between serogroups is common, and definitive serovar identification requires culture and genetic typing [11, 24].

What are the limitations of the MAT?

Limitations include the need for live leptospiral cultures (biosafety level 2), labour intensity, subjective reading, cross-reactivity, interference from vaccine antibodies, and poor sensitivity in the early acute phase before antibody production [6, 9, 16].

Is MAT used in wildlife serosurveillance?

Yes, MAT is widely applied in wildlife studies, including bats, coatis, sea lions, and other species, using panels selected based on local serovar prevalence [1, 17, 20].

How is MAT being improved with computational methods?

Deep learning and convolutional neural networks are being developed to automate endpoint reading, reduce inter-observer variability, and standardise interpretation across laboratories [8, 13].

What is the role of MAT compared to PCR in diagnosis?

PCR detects active infection during the bacteraemic phase and identifies renal shedders, whereas MAT provides serological evidence of past or current infection with serovar-level resolution [9, 16]. The two methods are complementary and best used together.

References

[1] Dos Santos GS, Silva DBN, Guedes IB, et al. Serological and molecular detection of Leptospira spp. in ring-tailed coatis (Nasua nasua) from an Ecological Park. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42384097/

[2] Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

[3] Rathinam SR, Vedhanayagi R, Thundikandy RT, et al. Leptospiral uveitis: A late complication of systemic leptospirosis. Indian J Med Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42165714/

[4] Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

[5] Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

[6] Le Turnier P, Oberlis M, Lavergne A, et al. Leptospirosis seroprevalence and exposure factors in three informal settlements of French Guiana: An opportunistic survey. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41284749/

[7] Azócar-Aedo L, Meniconi G, Pino-Olguín C, et al. Seropositivity for Pathogenic Leptospira in Dogs, Cats, and Horses at a Teaching Veterinary Hospital in Southern Chile. Trop Med Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41003563/

[8] Nakano R, Oyamada Y, Ozuru R, et al. Emulating visual evaluations in the microscopic agglutination test with deep learning. J Microbiol Methods. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40915619/

[9] Hamer M, Saraullo V, Esteban M, et al. Enhanced detection of Leptospira in cattle: Comparative performance of loop-mediated isothermal amplification, polymerase chain reaction and serological methods. Vet Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40780028/

[10] Marić J, Subić I, Stojiljković M, et al. Leptospiral shedding and seropositivity in asymptomatic stray dogs in Bosnia and Herzegovina. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40744134/

[11] Yanagihara Y, Masuzawa T, Shingai M, et al. A Case of Infection with Leptospires from Three Different Serovars During a Flood in the Philippines. Am J Trop Med Hyg. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40602382/

[12] Blanco RM, Dos Santos Lima E, Pinhata JMW, et al. In-House IgM Dot-Blot Assay for Serodiagnosis of Human Leptospirosis: Development, Standardisation, and Performance Evaluation. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40572195/

[13] Hassan M, Rosli SNZ, Mohamed Tahir NA, et al. Enhancing leptospirosis screening using a deep convolutional neural network with microscopic agglutination test images. Biol Methods Protoc. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40567354/

[14] Cardoso TL, Wozeak DR, Pereira IL, et al. Chimeric recombinant protein (rErpY-LemA) as innovative tools for animal leptospirosis serodiagnosis. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40348209/

[15] de Lisbôa Padilha M, Ricardo Bezerra de Melo L, Henrique Limeira C, et al. Prospective evaluation of Leptospira spp. infection in goats maintained in field conditions in the Caatinga biome, Brazil. Rev Argent Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40199688/

[16] Ciurariu E, Prodan-Barbulescu C, Mateescu DM, et al. Diagnostic Advances in Leptospirosis: A Comparative Analysis of Paraclinical Tests with a Focus on PCR. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40142559/

[17] Peters M, Field CL, Hortensius LM, et al. Evaluation of Two Serologic Tests for Rapid Detection of Anti-Leptospira Antibodies in California Sea Lions (Zalophus californianus). J Wildl Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39918883/

[18] Furlanello T, Mazzotta E, Bertasio C, et al. The Challenge of Bacterial Strain Identification: Leptospira interrogans Serovars Australis in a Dog and Long-Term Clinical Follow-Up. Trop Med Infect Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39728812/

[19] Sarangi S, Vijaya Bharathi M, Madhanmohan M, et al. Molecular and serological detection of acute canine leptospirosis and associated predictive risk factors in and around Chennai, India. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39549929/

[20] Nunes Batista JM, Barbosa Guedes I, Messias Vila E, et al. Serological and molecular investigation of Leptospira spp. in bats (Chiroptera, Mammalia) from Brazil. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39542229/

[21] Benvin I, Fitz D, Mojčec Perko V, et al. Insights into Leptospira spp. infection in pet cats in Croatia: Clinical, serological and molecular findings with emphasis on the potential important role of serogroup Pomona. Acta Trop. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39542153/

[22] Franco MB, Gomes LR, Rostkwoska C, et al. Under-Reporting of Human Leptospirosis Cases in Cities of Triângulo Mineiro, Minas Gerais, Brazil. Trop Med Infect Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39453256/

[23] Kumar KV, Bokade PP, Pal A, et al. Detection of anti-leptospiral antibodies using recombinant ErpY-like lipoprotein based latex agglutination test for serodiagnosis of animal leptospirosis. Lett Appl Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39439206/

[24] Mummah RO, Gomez ACR, Guglielmino AH, et al. Navigating cross-reactivity and host species effects in a serological assay: A case study of the microscopic agglutination test for Leptospira serology. PLoS Negl Trop Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39365836/

[25] Ramsay L, Eberhardt C, Schoster A. Acute leptospirosis in horses: A retrospective study of 11 cases (2015-2023). J Vet Intern Med. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39194176/

[26] Mevada Y, Vinod KK, Balamurgan V, et al. Seroprevalence and Risk Factors Associated with Leptospirosis in High-Risk Occupational Groups in the State of Gujarat as Determined by IgM ELISA and MAT Test: A Cross-Sectional Study. Indian J Occup Environ Med. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39114107/

[27] Martínez ML, Esteban M, Sánchez C, et al. Study on the interference of vaccine antibodies with the serological diagnosis of leptospirosis in cattle. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39032443/

[28] Zečević I, Picardeau M, Vince S, et al. Association between Exposure to Leptospira spp. and Abortion in Mares in Croatia. Microorganisms. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38930421/

[29] Boonciew P, Saisongkorh W, Brameld S, et al. Improved Antibody Detection for Canine Leptospirosis: ELISAs Modified Using Local Leptospiral Serovar Isolates from Asymptomatic Dogs. Animals (Basel). 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38539991/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[30] Cardoso TL, de Freitas SB, Seixas Neto ACP, et al. Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection. Braz J Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38805148/

[31] Wainaina M, Lindahl JF, Mayer-Scholl A, et al. Molecular and serological diagnosis of multiple bacterial zoonoses in febrile outpatients in Garissa County, north-eastern Kenya. Sci Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38806576/

[32] Parra-Barrera EL, Bello-Piruccini S, Rodríguez K, et al. Serologically Confirmed Human Leptospirosis in Colombia, 2015-2020. Am J Trop Med Hyg. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39106850/

[33] Ramos-Vázquez JR, Sánchez-Montes S, Esparza-González SC, et al. Isolation and molecular identification of Leptospira santarosai and Leptospira interrogans in equines from eastern Mexico. Acta Trop. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38782111/

[34] Macchi MV, Suanes A, Salaberry X, et al. Leptospirosis as a cause of infertility in Uruguayan beef cattle. Prev Vet Med. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38772120/

[35] Carmona Gasca CA, Martínez González S, Castillo Sánchez LO, et al. The Presence of a Virulent Clone of Leptospira interrogans Serovar Canicola in Confirmed Cases of Asymptomatic Dog Carriers in Mexico. Microorganisms. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38674618/